Davis's Drug Guide
tapentadol
General
High Alert Medication: This medication bears a heightened risk of causing significant patient harm when it is used in error.
**REMS Drug**
Pronunciation:
ta-pen-ta-dol
To hear audio pronunciation of this topic, purchase a subscription or log in.Trade Name(s)
- Nucynta
- Nucynta ER
- Nucynta IR
Ther. Class.
(centrally acting)
Pharm. Class.
opioid agonists
Controlled Substance Schedule: II
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Vallerand, April Hazard., et al. "Tapentadol." Davis's Drug Guide, 19th ed., F.A. Davis Company, 2026. www.drugguide.com/ddo/view/Davis-Drug-Guide/109407/all/tapentadol.
Vallerand AHA, Sanoski CAC, . Tapentadol. Davis's Drug Guide. F.A. Davis Company; 2026. https://www.drugguide.com/ddo/view/Davis-Drug-Guide/109407/all/tapentadol. Accessed May 24, 2026.
Vallerand, A. H., Sanoski, C. A., & , (2026). Tapentadol. In Davis's Drug Guide (19th ed.). F.A. Davis Company. https://www.drugguide.com/ddo/view/Davis-Drug-Guide/109407/all/tapentadol
Vallerand AHA, Sanoski CAC, . Tapentadol [Internet]. In: Davis's Drug Guide. F.A. Davis Company; 2026. [cited 2026 May 24]. Available from: https://www.drugguide.com/ddo/view/Davis-Drug-Guide/109407/all/tapentadol.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - tapentadol
ID - 109407
A1 - Sanoski,Cynthia A,
AU - Vallerand,April Hazard,
AU - ,,
BT - Davis's Drug Guide
UR - https://www.drugguide.com/ddo/view/Davis-Drug-Guide/109407/all/tapentadol
PB - F.A. Davis Company
ET - 19
DB - Davis's Drug Guide
DP - Unbound Medicine
ER -